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Abstract: Corporate research and development (R&D) activities have long been highly concentrated in a handful of 
world cities. This is due to the fact that these cities (e.g., Tokyo, New York, London, and Paris) are home to the largest 
and most powerful transnational corporations and are globally important sites for innovative start-up firms that oper-
ate in the fastest growing industries. However, in tandem with the rapid technological changes of our age, corporate 
R&D activities have shifted towards newly emerging and now globally significant R&D centres, like San Jose, San 
Francisco, and Boston in the United States, and Beijing, Seoul, and Shenzhen in East Asia. In this paper, I will conduct 
a bibliometric analysis to define which cities are centres of corporate R&D activities, how different industries influence 
their performance, and what spatial tendencies characterise the period from 1980 to 2014. The bibliometric analysis is 
based upon an assumption that implies there is a close connection between the number of scientific articles published 
by a given firm and the volume of its R&D activity.
Results show that firms headquartered in Tokyo, New York, London, and Paris published the largest combined num-
ber of scientific articles in the period from 1980 to 2014, but that the growth rate of the annual output of scientific articles 
was much greater in Boston, San Jose, Beijing, and Seoul, as well as some Taiwanese cities. Furthermore, it can also be 
seen that those cities that have the largest number of articles; i.e., that can be considered as the most significant sites of 
corporate R&D in which firms operate in fast-growing industries, are primarily in the pharmaceutical and information 
technology industries. For these reasons, some mid-sized cities that are home to globally significant pharmaceutical or 
information technology firms are also top corporate R&D hubs.  
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Introduction
Since the beginning of the 1970s, but even in 
the past quarter century, the rate at which the 
global economy is restructuring has rapidly in-
creased. This restructuring has been characterised 
by, for example, the emergence of the new inter-
national division of labour (NIDL) (Fröbel et al. 
1980, Cohen 1981), as well as rapid technological 
changes (Dicken, 2007). Transnational corpora-
tions, as key orchestrators within the framework 
of economic globalization, have been relocating 
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manufacturing activities away from core indus-
trial countries towards developing countries for 
decades (Schoenberger, 1988; Dicken, 2007). As 
a result, some developing countries, especial-
ly China and India, have gradually become key 
actors in the world economy. Recently in these 
developing countries, many giant low-tech man-
ufacturing corporations and banks have been 
established, as well as a growing number of in-
novative small and medium-sized enterprises 
(Cheng, 2014), all of which have the power to 
significantly affect the world economy (Sauvant, 
2008). Furthermore, in the recent past, technolog-
ical change has occurred at a rapid pace due in 
part to fast-growing industries like nanotechnol-
ogy, biotechnology, and information technology 
Hullmann, Meyer 2003; Nicolini, Nozza 2008; 
Dernis et al. 2015). Naturally, core economies 
still dominate in these industries; however, some 
developing countries have become serious com-
petitors. For example, China has become a global 
player in the telecommunication and renewable 
energy industries. The gap between the economic 
performance of developed and developing coun-
tries has gradually narrowed, thanks not only to 
the fast economic growth of developing coun-
tries, but also to the large volume of foreign direct 
investments that target their corresponding R&D 
sector (Reddy, 2005). Several firms from devel-
oping countries have emerged as globally signif-
icant R&D investors (Hernández et al., 2015), and 
have themselves become major actors in global 
corporate R&D activities (Csomós, Tóth, 2016a). 
Clearly, the spatial distribution of corporate 
R&D activities is highly uneven, because of the 
fact that the majority of R&D-oriented firms, 
and even their research facilities, are concentrat-
ed in just a few cities in the world. According to 
Sassen’s (2001) global city concept, New York, 
London, Tokyo, and Paris are the most important 
sites for the production of innovation; i.e., they 
are expected to be the greatest centres of global 
corporate R&D activities. However, in tandem 
with the rapid technological changes of our age, 
corporate R&D activities have shifted towards 
newly emerging and globally significant R&D 
centres, like San Jose, San Francisco, and Boston 
in the United States (Rothwell et al., 2013), and 
Beijing, Seoul, and Shenzhen in East Asia. In 
recent years, these cities have become home to 
many R&D-oriented firms that did not even exist 
in the 1980s or 1990s. 
In this paper, I will conduct a bibliometric 
analysis to define which cities are centres of cor-
porate R&D activities, how different industries 
influence their performance, and what spatial 
tendencies characterise the period from 1980 to 
2014. The structure of this paper is as follows: 
First, I will present the reasons firms have scien-
tific articles; second, I will demonstrate the data 
and methodology by way of bibliometric analy-
sis; and finally, I will draw the conclusion.
Research background
How can corporate R&D activities be 
measured?
The volume of corporate R&D activities can 
be measured in different ways; for example, by 
counting the number of patents and/or the num-
ber of patent citations (Narin et al., 1987; Chang 
et al., 2012; Liu et al., 2006; Ribeiro et al., 2010; 
Ribeiro et al, 2014; Wang et al., 2011; Wong, 
Wang, 2015); by counting the amount in R&D 
expenditures (Granstrand, 1999; Kumar, 2001; 
Piergiovanni, Santarelli, 2013; Yoo, Moon, 2006); 
by defining the quantity and quality of research 
cooperation between firms and universities 
(Feng et al., 2015; Gao et al., 2011; Kneller et al., 
2014; Ramos-Vielba et al., 2010); and by the num-
ber of scientific articles authored or co-authored 
by researchers within the firms (Chang, 2014; 
Furukawa, Goto, 2006; Hicks et al., 1994; Hicks, 
1995; Hullmann, Meyer, 2003; Tijssen, 2004; 
Csomós, Tóth, 2016a). The latter method is con-
firmed by Narin et al. (1987: 144), who addressed 
the product life cycle of corporations:
“Corporate sales lead to corporate profits, which 
may be used in research and development to produce 
scientific innovations (scientific publications), which 
may lead to technological innovations (some of which 
will be patented), which is the catalyst for new prod-
ucts and more efficient processes, which will increase 
corporate profits.”
Thus, the number of scientific articles au-
thored/co-authored by corporate researchers or 
engineers can reflect upon the R&D capacity of 
firms. 
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Why do firms have scientific publications?
Not every firm publishes scientific papers; 
not even some that have many patents or a 
large budget for R&D expenditures. Although, 
it is generally believed that scientific publish-
ing is out of business organizations’ interest, 
firms publish papers, and they do it extensively 
(Hicks, 1995; Godin, 1996). Some firms contribute 
as many scientific articles to public literature as 
do medium-sized universities. For example, be-
tween 1980 and 2014, IBM published more scien-
tific articles than did Carnegie Mellon University, 
which was ranked 61st on the 2015 ARWU rank-
ing. Firms’ motivations regarding publishing 
differs between countries and across industries, 
and is largely influenced by the firm’s individual 
intellectual property strategy.
Next, I will provide an overview on the main 
reasons that firms contribute scientific articles, or 
at minimum, why firms have scientific articles 
indexed by bibliographic databases (e.g., Web of 
Science, Scopus).
Enabling defensive publications
A firm that has a patentable innovation can 
choose from any or all of these three options. 
First, the firm can obtain a patent; second, it can 
maintain trade secrecy; and third, it can publish 
an enabling defensive publication1 (Johnson, 
2014). Each option has benefits and risks that 
must be considered by the firm. The primary cost 
of a defensive publication is that it discloses the 
technical information of a product or process to 
the public, allowing competitors to capitalise on 
the innovation free of charge. Consequently, the 
innovating firm loses the right to exclude others 
from producing, selling, or using the patented in-
novation for the term of the patent, which is usu-
1 There are three options to protect innovations and in-
ventions (www.defensivepublications.org):
1. Obtain a patent. A patent is the right, granted by a 
government (in exchange for full disclosure), to ex-
clude others from making, using or selling products 
and services for a period of time (generally twenty 
years from the filing date).
2. Maintain secrecy. Innovations or inventions that are 
safeguarded from disclosure to others by policies and 
procedures are trade secrets. They are generally pro-
tected as long as secrecy is maintained.
3. Publish an enabling defensive publication.
ally 20 (+5 extra) years from the filing date. The 
main benefit of an enabling publication is that 
it destroys patent rights. According to Barrett 
(2002: 191), “the successful defensive publication 
renders the competitor’s invention obvious or 
lacking in novelty.”
Enabling defensive publications has been a 
component of comprehensive intellectual prop-
erty (IP) strategies of firms, even the largest 
transnational corporations, for decades. IBM pro-
duced its Technical Disclosure Bulletin between 
1958 and 1998 to publish defensive disclosures 
of inventions that were not formally patented. 
By having done this, IBM lost the possibility of 
patenting a number of innovations; however, the 
cumulative benefits enjoyed by the firm were 
much higher by destroying competitors’ patent 
rights (Barrett, 2002). The Bulletin, as prior art, is 
referred to in a US patent document more than 
48,000 times. Recently, defensive publication has 
become a widely used tool for small and medi-
um-sized enterprises (SMEs) to protect intellec-
tual property instead of patenting innovations. 
This choice of strategy has several reasons be-
hind it; however, the two most important ones 
are that patent applications are too expensive 
for SMEs (primarily in the United States), and it 
takes an average of two years from the date of 
filing to process an application (The New York 
Times, 2002).    
The phenomenon of defensive publication 
significantly contributes to the increase in the 
number of firms’ scientific publications2.
Enhancing the reputation of the firm
Many firms encourage their researchers and 
engineers to disclose knowledge publicly in or-
der to improve the external reputation of the firm 
(Hicks, 1995; Li et al., 2015). The improved reputa-
tion achieved via open knowledge disclosure can 
result in many benefits for a given firm (Muller, 
2 Defensive publications do not necessarily correspond 
to scientific publications. The Ip.com Prior Art Data-
base contains the largest number of enabling defen-
sive publications in the world. Although these de-
fensive publications may provide new knowledge by 
disclosing technical information about innovations, 
they are not considered scientific publications because 
they are not, among other things, peer-reviewed, not 
indexed in citation databases, etc.     
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Pénin, 2006). First, reputable firms can more eas-
ily find investors or obtain grants and subsidies. 
Second, they can more easily find potential collab-
orators with whom they can work on joint R&D 
projects. Third, these firms are more readily ac-
cepted for involvement in broader academic and 
industrial networks, resulting in additional bene-
fits for them. Fourth, these firms can attract and 
hire star researchers to work on the firms’ R&D 
projects. The improved reputation of the firm may 
counterweight the losses in profits (Allen, 1983), 
furthermore, reputational gains from being pub-
lished in scientific publications give credibility to 
a firm in its research field (Li et al., 2015). 
It can be concluded that scientific publication 
by firms can be considered on some level as qua-
si-scientific advertisements to target other inno-
vative firms and researchers, informing them of 
the firm’s leadership in relevant R&D projects.
Recruiting and retaining researchers
According to Godin (1996), firms are not gen-
erally interested in publishing scientific papers be-
cause their main motivation is to develop patenta-
ble innovations, which increases corporate profits. 
Therefore, before patenting innovations, research-
ers are not permitted by their firm to publish their 
results (i.e., disclose the technical information be-
hind innovations to the public). The reasoning is 
apparent: Patents are valuable in terms of money, 
while scientific publications are not (unless de-
fensive publishing is a component of the firm’s IP 
strategy) (Levi-Mazloum, von Ungern-Sternberg, 
1990; Pain, 2009). This restriction against pub-
lishing may discourage many researchers from 
working for firms for a higher salary but a lower 
scientific reputation, as many are more likely to 
be committed to working in academia for a lower 
salary but a greater scientific reputation. This con-
flict may lead to an extreme situation: either firms 
not being able to hire researchers for their R&D 
projects, or researchers leaving the firm upon be-
ing restricted from publishing. In order to avoid 
this situation, a compromise must be made be-
tween the management and researchers, in which 
researchers ask permission before publishing 
their scientific results, with cooperation from the 
management in allowing researchers to publish 
(Furukawa & Goto, 2006). This compromise has 
key benefits for both parties.
Collaboration with universities
Collaboration between firms and universities 
on R&D projects has always had great signifi-
cance. According to Kneller et al. (2014), “motiva-
tions for firms to engage with universities include 
accessing complementary research expertise for 
future business development, particularly for 
products that are in the design or early develop-
ment stage, furthermore, small or new firms tend 
to rely on universities for their core technologies.” 
The results of this kind of collaboration can be 
patentable innovations (which are important to 
the firm), as well as joint scientific publications 
(which are important to academicians) (Ramos-
Vielba 2010). In many cases, corporate researchers 
and engineers contribute to the writing of a paper 
only by providing technical guidance, profession-
al supervision, and necessary data; they do not 
participate directly in the creation of the paper. 
However, as quasi co-authors, their names and 
their affiliations appear in the paper, which then 
will be indexed by bibliographic databases. Thus, 
the firm, as the affiliate of corporate researchers, 
will enjoy credit in a scientific publication, even if 
it was not directly involved in writing the paper.
Data collection
In this paper, I conducted a bibliometric anal-
ysis of data in the Scopus database (www.scopus.
com). Scopus is the largest abstract and citation 
database, containing almost 22,000 titles (20,800 
peer-reviewed journals, 367 trade publications, 
and more than 400 book series) from 5,000 pub-
lishers, in addition to 6.4 million conference 
papers. Scopus offers the most broad and inte-
grated coverage available of scientific, technical, 
medical, and social sciences including arts and 
humanities literature. In this analysis, I focus on 
full articles exclusively, leaving out of considera-
tion all other types of publications (for example, 
conference papers, book chapters, letters, and 
editorials), which do not necessarily go through 
a peer-review process. Articles, written by given 
firms’ researchers and engineers, have been as-
signed to cities as was indicated by Scopus.  
The 2015 EU Industrial R&D Investment 
Scoreboard ranks the world’s top 2,500 R&D-
investing firms, which together invested $681.9 
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billion in R&D, representing about 90 percent 
of the world’s total expenditure by businesses 
on R&D. Leading R&D investor firms are classi-
fied into 41 industry sectors, and are headquar-
tered in 475 cities across 40 countries worldwide 
(Hernández et al., 2015). However, only 1,027 out 
of the 2,500 firms have scientific articles indexed 
in Scopus, and these firms are headquartered 
in 261 cities. Researchers and engineers at these 
firms contributed a total number of 958,725 sci-
entific articles in the period from 1980 to 2014. 
Furthermore, it is needed to be mentioned that 
articles can be written by multiple authors who 
affiliate to multiple organizations, i.e. a given ar-
ticle can be assigned to not only one, but multiple 
corporations.
Results
General results of corporate scientific 
publishing
Correlation between industry sectors and 
number of scientific articles
Previous studies underline the fact that most 
R&D-oriented firms are involved in high-tech in-
dustries (e.g., pharmaceuticals, information tech-
nology, chemicals, and electronics), and as such, 
they publish the largest number of scientific 
publications (Godin, 1996; Chang, 2014). Table 1 
shows that the Pharmaceuticals & Biotechnology 
industry contributed nearly 29 percent of the 
total number of articles, even though the share 
of the number of firms that operate in this in-
dustry is under 13 percent. Thanks to Nippon 
Telegraph & Telephone (NTT), the number of ar-
ticles per firm is actually the largest in the Fixed 
Line Telecommunications industry, in which 
NTT contributed 64 percent of the total number 
of articles.
Table 2 shows those industry sectors of cities 
in which more than 10,000 articles were created 
in the period from 1980 to 2014. Recognizing the 
fact that the largest number of articles belongs 
to pharmaceuticals, it is not surprising that the 
Pharmaceuticals & Biotechnology category is 
the most important industrial component of 
leading cities. For example, 23 pharmaceutical 
firms headquartered in New York published as 
many articles as did 275 information technology 
firms (classified into the Software & Computer 
Services category) in the period from 1980 to 
2014. Furthermore, some leading cities (Tokyo, 
New York, and Paris) had more than one indus-
try in which firms published a very large number 
of articles; i.e., they carried out extensive R&D 
activities.
Table 1. Ranking industry sectors by the number of scientific articles published by firms in the period from 
1980 to 2014.
Rank Industrial sector (ICB-3D) No. of firms No. of articles (1980–2014)
No. of articles 
per firm
Percentage within 
the dataset
1 Pharmaceuticals & Biotechnology 317 276,215 871 28.81
2 Technology Hardware & Equipment 317 103,874 328 10.83
3 Electronic & Electrical Equipment 229 79,406 347 8.28
4 General Industrials 96 75,002 781 7.82
5 Software & Computer Services 275 69,606 253 7.26
6 Chemicals 133 62,012 466 6.47
7 Oil & Gas Producers 32 53,771 1680 5.61
8 Automobiles & Parts 155 45,379 293 4.73
9 Fixed Line Telecommunications 17 35,267 2075 3.68
10 Aerospace & Defence 56 24,233 433 2.53
11 Industrial Metals & Mining 40 18,710 468 1.95
12 Industrial Engineering 199 17,795 89 1.86
13 Food Producers 59 17,809 302 1.86
14 Leisure Goods 39 16,247 417 1.69
15 Health Care Equipment & Services 100 13,132 131 1.37
16 Electricity 30 10,799 360 1.13
17–41 Other industry sectors 412 39,468 – 4.12
TOTAL 2506 958,725 383 100.00
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Cities as centres of global corporate R&D
The preceding industry-specific ranking sug-
gests that Tokyo and New York are leading sites 
of corporate R&D. Table 3 illustrates that these 
cities were home to two-thirds of the total num-
ber of articles published by selected firms in the 
period from 1980 to 2014. Tokyo is the leading 
headquarter location of corporate R&D investors, 
as headquarters to nine percent of all firms in the 
data set. As home to 78 firms on the list, New York 
is also a significant headquarters city; moreover, 
New York-based IBM, Pfizer, Honeywell, and 
Merck are all Top 10 firms in terms of the number 
of scientific articles published. It is not surpris-
ing that Paris and London, two European glob-
al cities, are in leading positions, because both 
cities are strong pharmaceutical industry bases 
(London-based firms include GlaxoSmithKline 
and AstraZeneca; Paris-based firms include 
Sanofi and Servier), furthermore Paris is home to 
Alcatel-Lucent, which published the second-larg-
est number of scientific articles in the 1980 to 2014 
time frame, after IBM.   
The four global cities, New York, London, 
Tokyo, and Paris, are followed by Basel 
(Switzerland) and San Jose (United States). Basel 
is a leading site in the international pharmaceu-
tical industry: Basel-based Novartis and Roche 
both belong to Top 10 firms in terms of the num-
ber of published scientific articles. Table 3 shows 
that Basel is home to only eight significant cor-
porate R&D investors, but San Jose is the head-
quarters of 110 relevant firms. In the period from 
1980 to 1984, the listed Basel-based firms pub-
lished 2.4 times as many articles as did the firms 
in San Jose. This ratio lessened to 1.2:1 in the pe-
riod from 2009 to 2014, emphasizing that the gap 
between Basel and San Jose is closing.  
It should be noted that in the period from 1980 
to 2014, the vast majority of the total number of 
Table 2. Ranking industry sectors in cities by the number of scientific articles published by firms.
Rank City/Metro Country Industrial sector (ICB-3D) No. of 
firms
No. of articles 
(1980–2014)
Percentage with-
in the sector
1 New York United States Pharmaceuticals & Biotechnology 23 69,871 25.30
2 London United King-dom Pharmaceuticals & Biotechnology 8 42,646 15.44
3 New York United States Software & Computer Services 13 39,742 57.10
4 Basel Switzerland Pharmaceuticals & Biotechnology 4 39,062 14.14
5 Tokyo Japan Electronic & Electrical Equipment 24 35,548 44.77
6 Paris France Technology Hardware & Equip-ment 4 32,786 31.56
7 New York United States General Industrials 4 26,172 34.90
8 San Jose United States Technology Hardware & Equip-ment 63 22,502 21.66
9 Tokyo Japan Fixed Line Telecommunications 1 22,467 63.71
10 Beijing China Oil & Gas Producers 3 18,575 34.54
11 Paris France Pharmaceuticals & Biotechnology 8 17,885 6.48
12 Tokyo Japan Software & Computer Services 6 17,126 24.60
13 Tokyo Japan General Industrials 10 16,670 22.23
14 Tokyo Japan Pharmaceuticals & Biotechnology 15 16,654 6.03
15 Amsterdam Netherlands General Industrials 1 14,385 19.18
16 Cologne Germany Pharmaceuticals & Biotechnology 1 13,538 4.90
17 Munich Germany Electronic & Electrical Equipment 2 13,252 16.69
18 Tokyo Japan Automobiles & Parts 21 13,022 28.70
19 Indianapolis United States Pharmaceuticals & Biotechnology 1 12,765 4.62
20 Philadelphia United States Chemicals 3 11,972 19.31
21 Tokyo Japan Chemicals 28 10,862 17.52
22 Detroit United States Automobiles & Parts 10 10,678 23.53
23 Nagoya Japan Automobiles & Parts 12 10,139 22.34
24 Bridgeport United States General Industrials 1 10,031 13.37
25–602 Cities’ other industry sectors 1410 420,375
TOTAL 1676 958,725
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scientific articles (87.44 percent) were published 
by firms located in developed countries. Out of 
the 34 top-ranked cities (see Table 3), 17 cities 
are located in the United States, 12 in Western 
Europe, three in Japan, and one in South Korea. 
The category of leading cities in developing 
countries is represented only by Beijing.      
The most intensive period of publishing
The United States is the dominant actor in cor-
porate R&D activities. In the period from 1980 to 
2014, 38 percent of the total number of scientific 
articles came from US firms. Western Europe and 
Japan are both important locations of corporate 
R&D activities as well, publishing 33 percent and 
22 percent of the total number of articles, respec-
tively. All the other countries play a minor role 
in global corporate R&D, contributing only seven 
percent of the total number of articles. It is im-
portant to now analyse the spatial dynamics of 
scientific publishing.
Figure 1 shows the most intensive period of 
publishing by city; i.e., a five-year-long period 
in which firms located in a given city published 
the largest number of scientific articles. Cities are 
classified into three groups, depending on wheth-
er their most intensive period of publishing fell 
Table 3. Ranking cities by the total number of scientific articles published by headquartered firms.
Rank City/Metro* Country No. of firms No. of articles (1980–2014)
Percentage within 
the dataset
1 Tokyo Japan 227 171,917 17.93
2 New York United States 78 140,329 14.64
3 Paris France 70 72,173 7.53
4 London United Kingdom 84 60,751 6.34
5 Basel Switzerland 8 41,098 4.29
6 San Jose United States 110 29,088 3.03
7 Osaka Japan 78 26,774 2.79
8 Chicago United States 34 20,220 2.11
9 Beijing China 63 19,607 2.05
10 Amsterdam Netherlands 14 19,545 2.04
11 Seoul South Korea 66 18,629 1.94
12 Munich Germany 22 17,127 1.79
13 Dallas United States 12 16,879 1.76
14 Bridgeport United States 9 16,244 1.69
15 Boston United States 84 14,549 1.52
16 Cologne Germany 4 13,656 1.42
17 Philadelphia United States 23 12,960 1.35
18 Indianapolis United States 3 12,765 1.33
19 Nagoya Japan 32 11,876 1.24
20 Detroit United States 11 10,678 1.11
21 Washington United States 24 10,407 1.09
22 Oxnard United States 4 7919 0.83
23 San Francisco United States 89 7292 0.76
24 Houston United States 15 7069 0.74
25 The Hague Netherlands 2 6981 0.73
26 Copenhagen Denmark 16 6848 0.71
27 Seattle United States 16 6591 0.69
28 Zurich Switzerland 25 6426 0.67
29 Mainz Germany 1 5843 0.61
30 Helsinki Finland 20 5531 0.58
31 Minneapolis United States 17 5256 0.55
32 Cincinnati United States 3 5098 0.53
33 Midland, Michigan United States 1 5082 0.53
34 Ludwigshafen Germany 1 5056 0.53
35–261 Other cities – 929 120,461 12.56
TOTAL 2195 958,725 100.00
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into the time frame 1) between 1980 and1984, and 
1999 and 2003; 2) between 2000 and 2004, and 
2009 and 2013; or 3) between 2010 and 2014. It 
can be seen that the three major areas: the United 
States, Western Europe, and Japan, are spatially 
divided regarding their most intensive period of 
publishing. Perhaps Japan is an exception, be-
cause its key cities’ most intensive period came 
to an end before 2013; moreover, in the cases of 
Tokyo and Osaka, the two most important cities 
in terms of the number of articles, this five-year-
long period fell in the 1990s. 
Many major cities on the West Coast and the 
East Coast of the United States have become in-
ternational centres of corporate R&D activities, 
while cities in the Great Lakes region and the 
state of Texas have lost their leading positions. 
Information technology firms have contributed 
the largest number of scientific articles in Seattle 
and San Jose, while in the cases of Oxnard, San 
Diego, and San Francisco, pharmaceutical firms 
have published a great number of articles. On 
the East Coast of the United States, Boston-based 
biotechnology and pharmaceutical firms have 
contributed the largest number of articles; fur-
thermore, some highly specialised firms located 
in small and medium-sized cities have also pub-
lished a great number of articles (e.g., Corning, 
New York: Corning Inc.; Hartford, Connecticut: 
United Technologies). 
The Great Lakes region and the state of Texas 
are home to many transnational corporations that 
operate in traditional industries, like oil, chem-
icals, and automotive. Some of these firms had 
once been among the world’s largest firms (e.g. 
General Motors and ExxonMobil), but after the 
recession of the late 2000s, and in part due to the 
recent low oil prices, they have come into a crisis, 
or in some cases, have been recovering slowly. 
Because of their financial problems, these firms 
have cut their R&D expenditures and reduced 
the size of the R&D staff, which has naturally re-
sulted in a decrease in the number of scientific 
articles. 
In the period from 1980 to 2014, the largest 
number of scientific articles in the United States 
Fig. 1. Mapping spatial distribution of leading cities as centres of corporate R&D in light of the most intensive 
period of publishing.
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was published by New York-based firms. New 
York is home to several global pharmaceuti-
cal firms, including Merck, Pfizer, Johnson & 
Johnson, and Bristol-Myers Squibb, whose most 
intensive year of publishing was 2011; however, 
since that time, there has been a significant de-
crease. The peak of scientific publishing within 
the information technology industry, which is 
the second most dominant industry sector in 
New York in terms of scientific output, was 1989 
to 1993, but since that time, it has also witnessed 
a decrease in the number of articles published.
In Europe, cities that are home to large pharma-
ceutical firms; for example, Dublin, Copenhagen, 
Basel, and Darmstadt, showed a marked increase 
in the number of scientific articles. The most sur-
prising among these cities is Dublin, a relative 
newcomer to the pharmaceutical industry. Basel 
and Darmstadt have long been home to major 
pharmaceutical firms: the histories of Basel-based 
Roche and Novartis, and that of Darmstadt-based 
Merck, are inseparable from the histories of their 
headquarter cities. Copenhagen is the European 
centre of several medium-sized pharmaceuti-
cal firms and fast-growing biotechnology firms, 
which were all founded in Denmark. In contrast 
with these cities, Dublin has attracted pharma-
ceutical firms (and some more large research-ori-
ented firms) from other countries, especially from 
the United States. US firms, including Allergan, 
Perrigo, Eaton, Seagate, and Accenture, relocated 
their headquarters, and in some cases, the entire 
firm, to Dublin, because the Irish capital offered 
low corporate taxes and well-developed business 
infrastructure (The New York Times, 2015).
However, as illustrated in Table 3, the most 
significant European sites for corporate R&D 
were Paris and London. Firms in these two cities 
published the largest number of scientific articles 
in the period from 1980 to 2014. For London-
based firms, the most intensive period of pub-
lishing was 2007 to 2011, but by 2010 to 2014, 
a decrease of less than five percent occurred. 
In contrast, firms in Paris published the largest 
number of articles in the period from 1996 to 
2000, and since then the city showed a 46 percent 
decline by 2010 to 2014. In London, two glob-
al pharmaceutical firms, GlaxoSmithKline and 
AstraZeneca, published 59 percent of the arti-
cles. The decline in London’s annual output was 
mainly attributed to GlaxoSmithKline, which 
decreased its publishing activity by nine percent 
by 2014. In Paris, there were two dominant firms 
as well: Alcatel-Lucent, a global telecommuni-
cations equipment firm, and Sanofi, one of the 
world’s largest pharmaceutical firms. These two 
firms published 64 percent of all articles of Paris. 
Alcatel-Lucent contributed about 33,000 articles 
in the period from 1980 to 2014, about 45 percent 
of the total number of the Paris-based firms’ sci-
entific articles. Alcatel-Lucent published 7,323 ar-
ticles in its most intensive period of 1987 to 1991. 
Its less intensive period was 2010 to 2014, when 
the firm only contributed 1,095 articles, which 
translates to an 85 percent decrease in the number 
of articles over the course of 15 years. Since the 
beginning of the 2000s, Alcatel has desperately at-
tempted to compete with its Asian rivals (such as 
ZTE and Huawei), and even the company’s 2006 
acquisition of the American Lucent did not result 
in success (Financial Times, 2012). Between 2006 
and 2015, the merged Alcatel-Lucent suffered a 
cumulative loss of $13 billion; meanwhile, both 
its revenues and market values fell significant-
ly. In 2006, Alcatel also acquired Lucent’s Bell 
Laboratories, one of the world’s largest research 
facilities and owner of a great number of patents 
and scientific publications. Alcatel-Lucent still 
had a globally outstanding R&D expenditure in 
2013, but it was not as much as the independent 
firms’ combined expenditures had been in the 
1990s (also reflected by the fact that the num-
ber of scientific articles has gradually decreased 
since the late 1980s). Alcatel-Lucent could not 
avoid selling its shares in other firms (e.g., in 
Thales and Genesys), or even its own acquisition. 
In 2016, Finland-based Nokia, one of the world’s 
largest telecommunication network equipment 
firms, acquired Alcatel-Lucent and Bell Labs, and 
organised them into quasi-autonomous subsid-
iaries. In conclusion, up until 2014, Paris main-
tained a very good position in global corporate 
R&D, but after losing control of Alcatel-Lucent, 
its leading role is fading away.   
Since the mid-1990s, significant changes have 
occurred in the spatial structure of corporate 
R&D in East Asia. The publishing activity by ma-
jor Japanese firms that ruled the 1990s has been 
gradually decreasing. For example, Tokyo- and 
Osaka-based firms published the largest num-
ber of scientific articles in 1996 respectively, but 
their annual output decreased by 45 percent by 
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the year 2014. Regarding corporate publishing 
activity, there is no dominant firm in Tokyo. The 
city’s 10 largest firms in terms of the number of 
articles contributed only 61 percent to the total 
number of articles published by all Tokyo-based 
firms. Although the annual output of articles has 
been decreasing in almost every industry sector, 
the negative change far exceeds the average in 
the electronic industry, one of Japan’s most im-
portant industries (The Economist, 2009). Among 
the Tokyo-based firms that contributed the larg-
est number of articles were several electronic 
firms, including Hitachi (ranked 2nd), NEC (5th), 
Toshiba (6th), and Sony (11th), whose collective 
average annual output decreased by 34 percent 
from 1996 to 2014. In Osaka, another electronics 
giant, Panasonic, contributed the largest number 
of articles over the course of the study. Its most 
intensive year of publishing was in the mid-
1990s; however, its annual output had decreased 
by 50 percent by the year 2014. Further adding 
to the losses, the fourth-largest Osaka-based firm 
in terms of the number of articles published, 
Sharp, has since been acquired by the Taiwanese 
Foxconn.
In East Asia, Seoul and Beijing have recently 
shown a great increase in the number of articles 
published. Today these cities have become ma-
jor competitors to the Japanese cities, not only as 
command and control centres (see, for example, 
Csomós, Tóth, 2016b), but also as sites of corpo-
rate R&D. However, there is a notable difference 
between Seoul and Beijing, that in the case of 
Beijing, 95 percent of the articles come from oil 
firms (Sinopec, PetroChina, and CNOOC), while 
in Seoul, the most productive industry sector 
is electronics, having 42 percent of the articles. 
Andersson et al. (2014: 2969) claim that although 
Beijing has similar publication volumes as for 
example, London and Paris, it still occupies a 
peripheral position in the production of new sci-
entific breakthroughs. Recently, by establishing 
technology parks, Beijing has made a strong ef-
fort to attract foreign high-technology firms and 
Fig. 2. Annual output of scientific articles by leading firms in Top 10 cities (1980–2014).
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provide an innovative environment for domestic 
start-up firms (Zhou, 2005; Ramirez and Li, 2009; 
Zhang et al, 2011). 
Outside the above regions, there are some 
less significant cities that are sites of corporate 
R&D; for example, Rio de Janeiro, Mumbai, and 
Melbourne, but together, they contribute only as 
many scientific articles as does the medium-sized 
city of Minneapolis.  
Conclusion 
In this paper, I conducted a bibliometric anal-
ysis to determine which cities were considered 
to be the international sites of corporate R&D, 
and how the publication performance of leading 
firms headquartered in these cities has changed 
between 1980 and 2014. Results show that cit-
ies can be organised into five large R&D zones 
worldwide: the West Coast of the United States, 
the Great Lakes Region, the East Coast of the 
United States, Western Europe, and East Asia.
The West Coast of the United States: The heart of 
this region is the San Francisco Bay Area (includ-
ing San Jose and the cities of the Silicon Valley), 
which is the international centre of the infor-
mation technology industry. The dominant city 
within this region is San Jose, having the largest 
number of scientific articles. Furthermore, it can 
be observed that many San Jose-based firms have 
started to publish only since the mid-1990s, and 
as such, San Jose is one of the most dynamical-
ly growing sites of corporate R&D worldwide. 
Seattle, Oxnard, San Diego, and Los Angeles are 
also significant sites of corporate R&D; howev-
er, their combined number of scientific articles is 
less than 50 percent of that of San Jose. 
The Great Lakes Region: Chicago, Indianapolis, 
Detroit, Minneapolis, Cincinnati, and Midland 
are the most important sites of corporate R&D in 
this zone. It is a common characteristic of these 
cities that although large firms headquartered 
within them carry out significant R&D activities, 
and many of them operate in high-tech industries 
(e.g., chemicals, pharmaceuticals, and aerospace 
and defence), actually none of them belong to the 
fast-growing industries. Albeit the fact that cities 
in this zone are still important sites of corporate 
R&D, leading firms are publishing a decreasing 
number of articles year by year.
The East Coast of the United States: New York 
has the largest number of scientific articles pub-
lished by firms, due to its globally outstanding 
pharmaceutical and information technology in-
dustry. New York is followed by some mid-sized 
R&D hubs, such as Bridgeport, Philadelphia, and 
Washington, DC. In this zone, the closest com-
petitor to New York is Boston, the fastest-grow-
ing site of corporate R&D in the United States, 
especially in the fields of biotechnology and in-
formation technology. 
Western Europe: On the basis of the number of 
scientific articles, Paris and London are the ma-
jor sites of corporate R&D in Europe; however, 
with respect to the increase in the number of arti-
cles, cities in Southern Germany and Switzerland 
show the most rapid increase. Basel is a leading 
R&D hub of the international pharmaceutical in-
dustry. Furthermore, Copenhagen and Dublin 
also have a key role in the European corporate 
R&D. In the former, scientific articles primarily 
come from domestic biotechnology firms; in the 
latter, most of the articles are published by relo-
cated American firms.
East Asia: The most dramatic changes have 
occurred in this region. Tokyo is the largest cor-
porate R&D hub in the world: Tokyo-based firms 
published the largest combined number of arti-
cles in the period from 1980 to 2014; moreover, 
the city has had the largest annual output in 
terms of the number of scientific articles pub-
lished since the mid-1980s. However, the volume 
of this annual output has been gradually decreas-
ing; that is, year by year, Tokyo-based firms (and 
firms headquartered in Osaka and Nagoya) have 
been publishing fewer and fewer articles. In this 
region, Seoul and Beijing has become the most 
dynamically growing R&D hub, also reflected 
by the fact that firms headquartered in Seoul and 
Beijing have been publishing a rapidly grow-
ing number of scientific articles. The difference 
between Seoul and Beijing is that in the former, 
most articles are coming from high-tech firms, 
while in the latter, oil firms are publishing almost 
exclusively.
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